About FunDaMos
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Janssen-Cilag International NV
1
Clinical Trials at FunDaMos
During the past decade, FunDaMos conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder
2020-08-21
2022-07-15
Completed
676
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
2020-09-15
2023-11-24
Recruiting
720
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
2021-04-26
2024-07-19
Active, not recruiting
183
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
2022-06-22
2024-08-11
Recruiting
538
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
2022-09-22
2025-10-25
Recruiting
840
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at FunDaMos
According to Clinical.Site data, the most researched conditions in "FunDaMos" are
"Depressive Disorder, Major" (5 trials) and "Anhedonia" (1 trials). Many other conditions were trialed in "FunDaMos" in a lesser frequency.
Clinical Trials Intervention Types at FunDaMos
Most popular intervention types in "FunDaMos" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aticaprant" (2 trials), "SSRI/SNRI" (2 trials), "Esketamine" (1 trials), "Esketamine 28 mg" (1 trials) and "Esketamine 56 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at FunDaMos
The vast majority of trials in "FunDaMos" are
5 trials for "All" genders.
Clinical Trials Status at FunDaMos
Currently, there are NaN active trials in "FunDaMos".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in FunDaMos,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in FunDaMos, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".